INTRODUCTION
============

American tegumentary leishmaniasis (ATL) is a parasitic disease caused by protozoa of the genus *Leishmania spp.* It is one of the six most prevalent infectious and parasitic diseases on the planet, considered a public health problem by the World Health Organization (WHO). On average, WHO estimates that, every year, 350 million people are at risk to contracting the disease. In Brazil, approximately 35,000 new cases are notified per year[@B1] ^--^ [@B3].

In 2003, ATL autochthony was confirmed in all the federal units of Brazil[@B4]. The North, Northeast and Midwest regions have the highest number of reported cases of ATL with 46.08%, 26.56% and 15.14% in relation to the total number of cases reported in 2015, respectively[@B5]. In the State of Tocantins (TO), the incidence rate of ATL in 2012 was 31.18 cases per 100,000 inhabitants, well above the national rate of 11.86 cases per 100,000 inhabitants[@B6]. The central region of the State, where health centers of the municipalities of Palmas, *Paraíso, Guaraí* and Porto Nacional are located, concentrated the largest number of reported cases, accounting for approximately 60.0% of the cases reported in 2015[@B7].

Clinically, ATL corresponds to some forms of disease that are broadly classified as cutaneous, disseminated cutaneous, diffuse cutaneous and mucocutaneous. The incidence is mainly associated with areas of precarious socioeconomic conditions and with low levels of medical-sanitary infrastructure, deforestation and uncontrolled urbanization as the main causal factors of the disease expansion[@B8] ^,^ [@B9].

Due to the great territorial extension of the country and the presence of geographic areas with particular characteristics, the epidemiology of infection may be different in certain regions of Brazil. This reality represents a challenge for national disease control programs and, for this reason, the Ministry of Health has developed the ATL Surveillance Program with the main objective of diagnosing and treating the detected cases early, in addition to focusing on the identification and monitoring of the Brazilian territory with higher epidemiological prevalence[@B4]. Thus, characterization of the epidemiological profile of each endemic region is necessary for the establishment of specific strategies of prevention and control of ATL adapted to different realities of each locality, as well as the identification of the etiological agent for the institution of more efficient therapeutic schemes to the existing species in each region, minimizing the treatment resistance, the number of relapses and evolution to mucosal forms. Thus, the objective of this work is to outline the epidemiological profile of ATL and identify the species of *Leishmania* prevalent in the State of Tocantins.

MATERIAL AND METHODS
====================

Health regionalization in Tocantins
-----------------------------------

The State of Tocantins is in the Northern region of Brazil, with an area of 277,720.520 km^2^ and an estimated population of 1,496,880 inhabitants in 2014[@B10]. It is composed of 139 municipalities and these are divided into eight health regions[@B11], with the objective of promoting the organization of health actions and services based on the epidemiological profile, economic and cultural partnership, as well as infrastructure and access to each region. The eight regional health centers are: *Augustinópolis, Araguaína, Guaraí, Paraíso,* Palmas, Porto Nacional, Gurupi and *Dianópolis* ([Figure 1](#f1){ref-type="fig"}).

![Location of the eight health regions in the State of Tocantins in Brazil, South America. They are the regions of *Augustinópolis, Araguaína, Guaraí, Paraíso,* Palmas, Porto Nacional, Gurupi and *Dianópolis*](1678-9946-rimtsp-S1678-9946201759091-gf01){#f1}

Characterization of the epidemiological profile of ATL
------------------------------------------------------

Epidemiological data of ATL in Tocantins were made up of all the autochthonous cases of ATL in humans, diagnosed and notified to the Notification of Injury Information System (SINAN), referring to the eight regions of Health - TO, in the period from 2011 to 2015. Official notification data were provided by the Department of Technical Assistance of Leishmaniasis SVPPS / DVEDVZ / GDVZ of the State Department of Health of Tocantins (SESAU-TO). The variables used were sex, age, education, ethnic group, area of residence, confirmation criterion, evolution, clinical form, type of entry, occupation, initial drug administered.

Molecular characterization of *Leishmania species*
--------------------------------------------------

For identification of the *Leishmania* species prevalent in the State of Tocantins, 271 cases of ATL, confirmed by amastigote positivity in direct microscopic examination of Giemsa-stained slides specimens from lesion scarifications (DME), were enrolled from 32 different municipalities homogeneously distributed in the eight health regions of the State. The average number of samples per health region was 30 Giemsa-stained slides. Slides were provided by the ATL quality control department of the Central Laboratory of Public Health of Tocantins (LACEN-TO).

DNA extraction from Giemsa-stained slides was conducted using the commercial extraction kit protocol Illustra™ blood genomic Prep Mini Spin (GE Healthcare^®^, UK Limited, Buckinghamshire, Code: 28-9042-64), according to the manufacturer\'s instructions.

*Leishmania* DNA was amplified from 271 of the DNA samples using primers from the kinetoplast minicircle DNA designed by Passos *et al.* [@B12]. Amplification products were visualized on silver-stained 8% polyacrylamide gels. Primers were designed to amplify the conserved region of the minicircle of *Leishmania* kDNA producing fragments of 120 bp for *L. (Viannia) subgenus* and 116 bp for *L.* (*L.*) *Leishmania,* as described by Volpini *et al.* [@B13]. For confirmation of the subgenus *Viannia,* PCR products were digested with *Hae III* restriction enzyme, which has a specific site for subgenus *Viannia.* The 120 bp PCR product of *L.* (*V.*) produces two fragments of 40 bp and 80 bp, and the enzyme does not digest the *L.* (*L.*) *amazonensis.* After digestion,fragments were visualized in 15% silver-stained polyacrylamide gels as described by Volpini *et al.* [@B13].

The identification of *L (V.) braziliensis* species was carried out by amplification of the enzyme glucose-6-phosphate dehydrogenase (G6PD; EC 1.1.1.49), according to Castilho *et al.* [@B14]. In the assay, DNA was extracted as described above, then amplification was performed using primers that specifically amplify G6PD sequences of *L. (V.) braziliensis* (ISVB and ISVC). Amplification products were visualized on silver-stained 8% polyacrylamide gels.

Data analysis
-------------

The database of records from SINAN - TO was used to search for information on ATL. Data were arranged statistically in absolute and relative frequencies and incidence rates using Microsoft Office Excel^®^ version 2013, the found values were presented in tables and graphs allowing a better visualization of their evaluation. Maps were built using the Qgis program Sirgas 2000 version.

The present study was approved by the Research Ethics Committee (CEP) of the Clinical Hospital of the *Federal University of Goiás* - GO under the N° 35963214.6.0000.5078.

RESULTS
=======

Tocantins reported a total of 1,434 autochthonous cases of ATL to SINAN in the period from 2011 to 2015. The number of municipalities with case records reported to SINAN increased progressively over a 5-year period, characterizing a territorial expansion of the disease in the State. In 2011, from the total of 139 municipalities in the State of Tocantins, 81 cases of ATL were reported to SINAN, and at the end of the study years, only 6 municipalities had no cases of ATL ([Figure 2](#f2){ref-type="fig"}). The health regions with the highest incidences of ATL per 100,000 inhabitants were *Paraíso* regions 36.5 cases; Porto Nacional, 34.0 cases; *Dianópolis,* 28.7 cases and *Guaraí,* 26.5 cases ([Figure 3](#f3){ref-type="fig"}). Municipalities with the highest incidences of reported cases per 100,000 inhabitants were: *Tocantínea* (178.0 cases), Ponte Alta do Tocantins (140.0 cases), Lavandeira (127.0 cases) and Araguacema (123.0 cases). The year with the highest frequency of ATL notification was 2014 ([Figure 4](#f4){ref-type="fig"}).

![Geographical distribution of ATL in the State of Tocantins. Location of municipalities reporting cases of ATL in humans at SINAN, from 2011 to 2015. Number of municipalities reporting ATL cases in the years of study: 2011 (81 municipalities), 2012 (84 municipalities), 2013 (85 municipalities), 2014 (96 municipalities), 2015 (86 municipalities)](1678-9946-rimtsp-S1678-9946201759091-gf02){#f2}

![ATL notification incidence by municipality. Stratification of municipalities by incidence of reported cases of ATL, period 2011-2015, performed in the eight health regions that make up the State of Tocantins, in Brazil](1678-9946-rimtsp-S1678-9946201759091-gf03){#f3}

![Frequency of ATL notifications per year. The stratification per year of reported ATL cases, period 2011-2015, performed in the eight health regions that make up the State of Tocantins, Brazil](1678-9946-rimtsp-S1678-9946201759091-gf04){#f4}

Socio-demographic characteristics of reported cases ([Table 1](#t1){ref-type="table"}) revealed that the highest incidence of cases occurs in individuals: male (28.6); over 60 years of age (32.4); living in rural areas (38.5). In terms of ethnicity, education and disease-to-work ratio, there was a higher frequency of ATL in the mixed population (69.1%), with lower educational level (23.4%) and no disease at work (73.8%).

###### Socio-demographic and epidemiological characteristics of ATL cases reported to SINAN in the State of Tocantins, Brazil, from 2011 to 2015

  CHARACTERISTICS            TOTAL                                                
  -------------------------- ------------------------------------- ------ ------- ------
  **Age Group**                                                                   
                             \<1 year                              13     0.9     12.0
                             1-19 years                            262    18.3    9.6
                             20-39 years                           578    40.3    22.8
                             40-59 years                           387    27.0    27.2
                             \>60 years                            194    13.5    32.4
                             TOTAL                                 1434   100.0   --
  **SEX**                                                                         
                             Male                                  1076   75.0    26.8
                             Female                                358    25.0    9.9
                             TOTAL                                 1434   100.0   --
  **Race**                                                                        
                             White                                 190    13.2    --
                             Black                                 158    11.0    --
                             Yellow                                12     0.9     --
                             Brown                                 991    69.1    --
                             Indigenous                            57     4.0     --
                             N/A[\*](#TFN1){ref-type="table-fn"}   26     1.8     --
                             TOTAL                                 1434   100.0   --
  **Education**                                                                   
                             Illiterate                            71     4.9     --
                             Elementary School Incomplete          199    13.9    --
                             Complete primary education            177    12.3    --
                             Incomplete high school                335    23.4    --
                             Complete high school                  163    11.4    --
                             Incomplete Higher Education           06     0.4     --
                             Full Higher Education                 32     2.2     --
                             N/A[\*](#TFN1){ref-type="table-fn"}   384    26.8    --
                             Not applicable                        67     4.7     --
                             TOTAL                                 1434   100.0   --
  **Work-Related Illness**                                                        
                             Yes                                   94     6.5     --
                             No                                    1057   73.8    --
                             N/A[\*](#TFN1){ref-type="table-fn"}   283    19.8    --
                             TOTAL                                 1434   100.0   --
  **Residence Zone**                                                              
                             Rural                                 603    42.0    35.5
                             Urban                                 804    56.0    13.8
                             N/A[\*](#TFN1){ref-type="table-fn"}   27     2.0     --
                             TOTAL                                 1434   100.0   --

N/A= Not applicable or Not available.

The classification of disease and the clinical, diagnostic, therapeutic and evolution characteristics of cases were evaluated ([Table 2](#t2){ref-type="table"}). ATL cases were classified as new in 92.6% of reports. These cases were confirmed mainly by laboratory tests (74.0%) and the predominant clinical form was cutaneous in 94.5% of the cases. Eighty percent of patients were treated with the first choice drug recommended by the Ministry of Health, pentavalent antimonial, and the cure rate was 85.0%.

###### Clinical, diagnostic, therapeutic and evolution of ATL cases reported to SINAN in the State of Tocantins, Brazil, from 2011 to 2015

  CHARACTERISTICS             TOTAL                                        
  --------------------------- ------------------------------------- ------ -------
  **Input Type**                                                           
                              New case                              1329   92.6
                              Relapse                               58     4.0
                              N/A[\*](#TFN2){ref-type="table-fn"}   40     2.9
                              Transfer                              07     0.5
                              TOTAL                                 1434   100.0
  **Confirmation Criteria**                                                
                              Laboratory                            1062   74.0
                              Clinical-epidemiological              372    26.0
                              TOTAL                                 1434   100.0
  **Clinical Form**                                                        
                              Cutaneous                             1355   94.5
                              Mucosal                               79     5.5
                              TOTAL                                 1434   100.0
  **Drug of First Choice**                                                 
                              Pentavalent Antimony                  1155   80.6
                              Amphotericin B                        53     3.7
                              Pentamidine                           04     0.3
                              Others                                103    7.2
                              Not used                              32     2.2
                              N/A[\*](#TFN2){ref-type="table-fn"}   87     6.0
                              TOTAL                                 1434   100.0
  **Evolution**                                                            
                              Cure                                  1218   85.0
                              Abandonment                           31     2.2
                              Death by ATL                          04     0.3
                              Death by another cause                09     0.6
                              Transfer                              09     0.6
                              Change of diagnosis                   22     1.5
                              N/A[\*](#TFN2){ref-type="table-fn"}   141    9.8
                              TOTAL                                 1434   100.0

N/A= Not applicable or Not available.

PCR-RFLP technique was used to identify *Leishmania* in 271 amastigote-positive Giemsa-stained slides that yielded positive results by direct microscopic examination, from patients of 32 different municipalities of the eight health regions of the State of Tocantins, 252 (92.0%) samples were identified as belonging to the subgenus *L. (Viannia)* and 19 (8.0%), to *L. (L.) amazonensis* species ([Figure 5](#f5){ref-type="fig"}).

![Representative image of PCR amplified products from the conserved region of the *Leishmania* minicircle kDNA before and after Hae III digestion. In A: PCR amplicons, B: PCR product after HAE III digestion. In A1 and B1: molecular weight standard of 25 bp; In A2 and B2: *L. (V.) braziliensis* MHOM / BR / 1975 / M2903, WHO reference; In A3 and B3: *L. (L.) amazonensis* IFA / BR / 1967 / PH8, WHO reference; In A4-A10 and B4-B10: Isolate samples; In A11, negative control of the PCR. Polyacrylamide gel 8 and 15%, respectively, stained by silver](1678-9946-rimtsp-S1678-9946201759091-gf05){#f5}

PCR-G6PD technique was used in 252 positive samples for *Leishmania* species belonging to the subgenus *Viannia* and 226 (90.0%) samples were positive for *L. (V.) braziliensis* species ([Figure 6](#f6){ref-type="fig"}).

![PCR amplified products obtained with oligonucleotides *G6PD-ISVC* and *G6PD-ISB.* In 1: molecular weight standard of 100bp; 2: Negative Control; 3: *L. (V.) braziliensis* MHOM / BR / 1975 / M2903, WHO reference; 4-8: Samples. 8% polyacrylamide gel stained with silver](1678-9946-rimtsp-S1678-9946201759091-gf06){#f6}

The identification of the territorial distribution of molecularly characterized *Leishmania* species has shown that *L. (V.) braziliensis* is present in the 32 municipalities analyzed from the 8 health regions and that *L. (L.) amazonensis* was found in only 7 municipalities, 6 of which are located in the central region of Tocantins State ([Figure 7](#f7){ref-type="fig"}).

![Territorial distribution of *Leishmania* species in the State of Tocantins. Positive samples of DME were collected from 32 municipalities distributed homogeneously in the eight health regions of the State and characterized molecularly by PCR-RFLP and PCR-G6PD](1678-9946-rimtsp-S1678-9946201759091-gf07){#f7}

DISCUSSION
==========

In the last decades, epidemiological studies have suggested changes in the epidemiological behavior of ATL in Brazil. Initially, it was restricted to forest regions, having wild animals as reservoirs and where humans were accidentally infected when they eventually entered the forest. Progressively, more and more cases of ATL have been observed in practically deforested rural areas, in areas of ancient colonization, peri-urban regions and even in urban centers, being the disease related to adaptation of parasites and vectors to the environmental changes, having domestic animals as new reservoirs[@B9]. Thus, different epidemiological profiles, expressed by the endemic maintenance of cases from or close to outbreaks, the appearance of epidemic outbreaks associated with factors arising from the emergence of economic activities such as gold-digging, agricultural frontiers and extractivism, settlement of landless workers, constitute highly favorable environmental conditions for the transmission of disease[@B4].

The study reveals that the State of Tocantins presents socio-demographic characteristics of ATL similar to those described in other studies demonstrating that ATL continues to be endemic with a higher incidence in men living in rural areas or exercising professional activity linked to the field, such as agriculture or livestock[@B15] ^--^ [@B21], unlike other authors that showed greater endemicity in individuals living in urban areas[@B22] ^--^ [@B27].

The presentation of disease was classified into three epidemiological profiles[@B17]: 1) purely wildlife ATL - epidemic outbreaks associated with forest felling and disorderly forest exploration; 2) modified wild ATL (rural) - seasonal outbreaks, in areas with residual outbreaks of primary forest, at the interface of peridomiciliary areas and in forest areas, related to agriculture and linked to fluctuations in the population density of sand flies; and 3) periurban and urban ATL occuring in endemoepidemic, endodomicillary or peridomiciliary ways, in areas of ancient colonization, where the participation of domestic animals as reservoirs is suspected.

The State of Tocantins, as well as other regions of Brazil, presents a modified wild epidemiological profile. Having identified a greater cycle of ATL transmission in the rural environment: in humans who live or who develop activity linked to the field. To a lesser extent, a periurban and urban transmission cycle was also observedin individuals of both sexes and different age groups, with no expression of a professional standard related to disease, however, it is not possible to exclude the possibility of these individuals, to engage in tourism or leisure activities, such asfishing, hunting, camping, bathing in lakes and rivers, exposing them to environments compatible with the mode of transmission classically assigned to the infection.

The most commonly used method was the laboratory diagnosis (74.0%), mainly the scraping of the lesion for the preparation of Giemsa-stained slides (57.5%), followed by the Montenegro skin test (16.6%) and histopathology (8.8%). Although these tests are widely used and of low operational costs, in particular the Montenegro skin test and the Giemsa-stained slides, 15.6% did not had any of these tests performed to confirm the clinical suspicion. These and those who presented negative test results were classified exclusively by clinical-epidemiological criteria, totaling 26.0% of the suspected cases. This fact is acceptable since this method takes into account the characteristics of lesions and if the patient comes from an endemic region. However, an association between epidemiological, clinical and laboratory aspects would be ideal for the diagnosis of ATL, minimizing failures to detect new cases and change of diagnosis[@B22].

In the present study, we verified a diagnosis change in 22 cases, classified exclusively by the clinical-epidemiological form. This clearly demonstrates that non-use of existing laboratory resources exposes the patients to unnecessary risks since pentavalent antimonial therapy has a number of side effects, some of which are serious, such as cardiac arrhythmias[@B28].

The clinical form of ATL was predominantly cutaneous (94.5%), similar to the studies performed by Rocha *et al.* [@B25] and Xavier *et al.* [@B26], which also showed the cutaneous form as the clinical manifestation of higher incidence with 95.0% and 96.0%, respectively, in the States of Alagoas and Minas Gerais. Data also agree with those from the Ministry of Health, which estimates that only 3.0 to 5.0% of cases with skin lesions will develop the mucosal form of disease[@B3].

The percentage of cure of all reported cases (1,434) when analyzed globally is 85.0% (1218), consistent with what is found in other studies[@B18] ^,^ [@B26] ^,^ [@B29] ^,^ [@B30]. However, if only the confirmed cases are considered (-- 22 with change of diagnosis), treated (-- 31 who abandoned) and already closed (-- 141 without outcome), there were 1,240 cases and consequently 98.2% of clinical cure after treatment and only 1.5% of drug resistance and 4.0% of recurrence, revealing that the standard treatment scheme is effective in this population, since the recurrence rate is below the mean of 4.6%[@B30].

Molecular characterization using Giemsa-stained slides identified that, in 90.0% of samples, the most prevalent species of *Leishmania* in the region was *L. (V.) braziliensis* and in 8.0% of samples, *L. (L.) amazonensis* species ([Figure 6](#f6){ref-type="fig"}). PCR assay was developed on the basis of isoenzyme data and has been used as an identification target[@B14]. The test detected parasite DNA in Giemsa-stained slides from lesion scarification of ACL patients, all amastigote-positive by the direct microscopic examination. PCR discriminated *L. (Viannia) braziliensis* from the other sympatric species belonging to the same subgenus. This finding corroborates data[@B31] from a study that identified as the predominant phlebotomine species in the peridomiciliary environment in Tocantins, *Lutzomya whitmani,* one of the main species incriminated by the transmission of *L. (V.) braziliensis.* In Brazil, *L. (V.) braziliensis* is the most widely species distributed in the country associated with cutaneous and mucosal manifestations of ATL[@B3].

Similar data evidenced by our research group in the Midwest region of Brazil, where in *Goiás* and Mato Grosso, States bordering Tocantins, 93.5% of the identified species were *L. (V.) braziliensis* and 6.0% *L. (L.) amazonenesis* [@B32]. On the other hand, in the Amazon region, North of Brazil, the predominant species is *L. (V.) guyanensis* [@B33].

The gradual increase in reported cases of ATL throughout the years of study, with a peak of notification in 2014 (355 cases), suggests a possible flaw in the surveillance and control actions of the disease in Tocantins. This fact justified the intensification of health surveillance measures related to leishmaniasis with the accomplishment of seven technical capacities regarding the surveillance and control actions of leishmaniasis in different municipalities of the State with high levels of notification, as well as the holding of the II discussion forum on leishmaniasis. These measures contributed to a general reduction in the number of cases of ATL in the year 20 1 5[@B34] ^,^ [@B35].

The ATL is a compulsory notification disease, so it is possible to know the actual number of affected individuals in a population however, the observation of a considerable percentage of White/Ignorant cases regarding the evolution of disease (9,8%), (6.0%), or type of admission (2.9%) is a limiting factor of the study and reveals the need for a better qualification of health service professionals who fill out the notification forms in order to reduce data inconsistencies and consequently improve the information system (SINAN).

Knowing the population affected by ATL in our country is important for effective measures of the disease control to be established. Differences in morbidity, response to treatment and prognosis, related to *Leishmania* species, evidenced the need to characterize the most prevalent parasite species in different regions of Brazil that have different epidemiological characteristics.
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